אסטרוגנוס ® 0.3 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

ESTROGENS CONJUGATED 0.3 MG

Disponible depuis:

SALOMON,LEVIN & ELSTEIN LTD

Code ATC:

G03CA57

forme pharmaceutique:

TABLETS

Mode d'administration:

PER OS

Fabriqué par:

TEVA WOMEN'S HEALTH INC., USA

Groupe thérapeutique:

CONJUGATED ESTROGENS

indications thérapeutiques:

Estrogenus tablets are indicated in the:1. Treatment of moderate to severe vasomotor symptoms associated with menopause. 2. Treatment of moderate to severe vaginal dryness and pain with intercourse, symptoms of vulvar and vaginal atrophy, associated with menopause. When prescribing solely for the treatment of moderate to severe vaginal dryness and pain with intercourse, topical vaginal products should be considered.

Date de l'autorisation:

2012-04-01